Product Code: TMRGL85195
TMR's report on the global DNA and gene cloning services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global DNA and gene cloning services market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global DNA and gene cloning services market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the DNA and gene cloning services market.
The report delves into the competitive landscape of the global DNA and gene cloning services market. Key players operating in the global DNA and gene cloning services market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global DNA and gene cloning services market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
2. Assumptions and Research Methodology
3. Executive Summary: Global DNA and Gene Cloning Services Market
4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global DNA and Gene Cloning Services Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Top 3 players operating in the market space
- 5.2. Key Mergers & Acquisitions
- 5.3. Regulatory Scenario
- 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short-/ Mid-/ Long-term impact)
6. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product Type, 2017-2031
- 6.3.1. Gene Synthesis
- 6.3.2. Custom Cloning
- 6.3.3. Sub-cloning
- 6.3.4. Others
- 6.4. Market Attractiveness Analysis, by Product Type
7. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. DNA Sequencing
- 7.3.2. Mutagenesis
- 7.3.3. Genotyping
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, by Application
8. Global DNA and Gene Cloning Services Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Academic & Research Institutes
- 8.3.2. Pharmaceutical & Biotechnology Companies
- 8.3.3. Others
9. Global DNA and Gene Cloning Services Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
10. North America DNA and Gene Cloning Services Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product Type, 2017-2031
- 10.2.1. Gene Synthesis
- 10.2.2. Custom Cloning
- 10.2.3. Sub-cloning
- 10.2.4. Others
- 10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. DNA Sequencing
- 10.3.2. Mutagenesis
- 10.3.3. Genotyping
- 10.3.4. Others
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Academic & Research Institutes
- 10.4.2. Pharmaceutical & Biotechnology Companies
- 10.4.3. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product Type
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe DNA and Gene Cloning Services Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product Type, 2017-2031
- 11.2.1. Gene Synthesis
- 11.2.2. Custom Cloning
- 11.2.3. Sub-cloning
- 11.2.4. Others
- 11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. DNA Sequencing
- 11.3.2. Mutagenesis
- 11.3.3. Genotyping
- 11.3.4. Others
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Academic & Research Institutes
- 11.4.2. Pharmaceutical & Biotechnology Companies
- 11.4.3. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product Type
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Latin America DNA and Gene Cloning Services Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product Type, 2017-2031
- 12.2.1. Gene Synthesis
- 12.2.2. Custom Cloning
- 12.2.3. Sub-cloning
- 12.2.4. Others
- 12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. DNA Sequencing
- 12.3.2. Mutagenesis
- 12.3.3. Genotyping
- 12.3.4. Others
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Academic & Research Institutes
- 12.4.2. Pharmaceutical & Biotechnology Companies
- 12.4.3. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. Brazil
- 12.5.2. Mexico
- 12.5.3. Rest of Latin America
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product Type
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Middle East & Africa DNA and Gene Cloning Services Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product Type, 2017-2031
- 13.2.1. Gene Synthesis
- 13.2.2. Custom Cloning
- 13.2.3. Sub-cloning
- 13.2.4. Others
- 13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. DNA Sequencing
- 13.3.2. Mutagenesis
- 13.3.3. Genotyping
- 13.3.4. Others
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Academic & Research Institutes
- 13.4.2. Pharmaceutical & Biotechnology Companies
- 13.4.3. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. GCC Countries
- 13.5.2. South Africa
- 13.5.3. Rest of Middle East & Africa
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product Type
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (by tier and size of companies)
- 14.2. Market Share Analysis, by Company, 2021
- 14.3. Company Profiles
- 14.3.1. Aragen Life Sciences
- 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.1.2. Company Financials
- 14.3.1.3. Growth Strategies
- 14.3.1.4. SWOT Analysis
- 14.3.2. Bio-Techne
- 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.2.2. Company Financials
- 14.3.2.3. Growth Strategies
- 14.3.2.4. SWOT Analysis
- 14.3.3. Charles River Laboratories
- 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.3.2. Company Financials
- 14.3.3.3. Growth Strategies
- 14.3.3.4. SWOT Analysis
- 14.3.4. Curia
- 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.4.2. Company Financials
- 14.3.4.3. Growth Strategies
- 14.3.4.4. SWOT Analysis
- 14.3.5. Eurofins
- 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.5.2. Company Financials
- 14.3.5.3. Growth Strategies
- 14.3.5.4. SWOT Analysis
- 14.3.6. GenScript
- 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.6.2. Company Financials
- 14.3.6.3. Growth Strategies
- 14.3.6.4. SWOT Analysis
- 14.3.7. Integrated DNA Technologies
- 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.7.2. Company Financials
- 14.3.7.3. Growth Strategies
- 14.3.7.4. SWOT Analysis
- 14.3.8. MedGenome
- 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.8.2. Company Financials
- 14.3.8.3. Growth Strategies
- 14.3.8.4. SWOT Analysis
- 14.3.9. Sino Biological
- 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.9.2. Company Financials
- 14.3.9.3. Growth Strategies
- 14.3.9.4. SWOT Analysis
- 14.3.10. Syngene
- 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.10.2. Company Financials
- 14.3.10.3. Growth Strategies
- 14.3.10.4. SWOT Analysis
- 14.3.11. Twist Bioscience
- 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.11.2. Company Financials
- 14.3.11.3. Growth Strategies
- 14.3.11.4. SWOT Analysis